MorphoSys AG sell ValueFreak
Summary
This prediction ended on 28.11.13 with a price of €56.50. The price for MorphoSys AG massively increased, which is bad news for the SELL prediction by ValueFreak. ValueFreak has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | -1.419% | -1.419% | 133.298% | -0.692% |
| iShares Core DAX® | -2.926% | -3.811% | 9.621% | 12.399% |
| iShares Nasdaq 100 | 4.462% | 7.635% | 33.690% | 60.293% |
| iShares Nikkei 225® | 0.306% | -0.065% | 4.201% | 4.153% |
| iShares S&P 500 | 2.488% | 4.185% | 27.301% | 50.529% |
Comments by ValueFreak for this prediction
In the thread Morphosys AG diskutieren
Zuviel Spekulation um diesen Wert
Sell in May and go away - ich probiere es mal mit der Morphosys. Wegen des guten Runs sind hier zuviele spekulative Anleger investiert. Da kann es schnell abwärts gehen, wenn es nicht mehr vorangeht.